h1b friday october 16, 2015 impact of clinical pharmacist and health psychologist on integrated team...
TRANSCRIPT
H1b Friday October 16, 2015Impact of Clinical Pharmacist and Health Psychologist on Integrated Team Based Care: Transforming the System and Patient Care Experience to a Higher Level
Anne Van Dyke, Ph.D., ABPPElena Kline, PharmD
Lori Lackman-Zeman, Ph.D.Paul Misch, M.D.
Collaborative Family Healthcare Association 17th Annual ConferenceOctober 15-17, 2015 Portland, Oregon U.S.A.
Faculty Disclosure
The presenters of this session• have NOT had any relevant financial
relationships during the past 12 months
Learning Objectives
At the conclusion of this session, the participant will be able to:
• Describe the roles of clinical pharmacists and health psychologists on the integrated care team
• List the areas of patient and provider satisfaction associated with having clinical pharmacists and health psychologists as part of the IC team
• Describe process of doing a cost savings analysis to support adding a clinical pharmacist to your team
• Identify the steps to implement system change which paves the way for sustainable IC team based care
Bibliography/References
1. Croghan TW, Brown JD. (2010). Integrating mental health treatment into the patient centered medical home. AHRQ Publication No. 10-0084-EF. Rockville, MD: U.S. Department of Health and Human Services
2. Mountainview Consulting Group (2013). Primary Care Behavioral Health Toolkit. pcpci.org.
3. Park I, Sutherland SE, Ray L, Wilson CG. (2014). Financial implications of pharmacist-led Medicare annual wellness visits.
Journal of the American Pharmacists Association, Jul-Aug; 54(4):435- 40. doi:10.1331/JAPhA.2014.13234.
Bibliography/References4. Patterson BJ, Solimeo SL, Stewart KR, Rosenthal GE, Kaboli J, Lund BC.
(2015). Perceptions of pharmacists’ integration into patient-centered medical home teams. Research in Social and Administrative Pharmacy, Jan-Feb; 11(1):85-89. doi:10.1016/j.sapharm.2014.05.005. Epub 2014 May 29.
5. Peek CJ, Cohen DJ, deGruy III FV. (2014). Research and evaluation in the transformation of primary care. American Psychologist, 69
(4), 430- 442.
6. Peikes DN, Reid RJ, Day TJ, Cornwell DD, Dale SB, Baron RJ, Brown RS, Shapiro RJ. (2014). Staffing patterns of primary care practices in
the comprehensive primary care initiative. The Annals of Family Medicine, Mar-Apr;12(2):142- 9.doi:10.1370/afm.1626.
Learning Assessment
• A learning assessment is required for CE credit
• A question and answer period will be conducted at the end of this presentation
• Beaumont Health is an 8 Hospital System in SE Michigan
• Beaumont – Troy ~500 bed hospital
• OUWB New Medical School • Family Medicine Residency
Program– 14 faculty (MD & DO)– 24 residents– 1 Physician’s Assistant (PA)– 35,000 patient visits / year
Who We Are: Beaumont Family Medicine
The Integrated Care Team:• Faculty Physicians• Residents / Medical
students• Medical Assistants / Nurses• Health Psychologists• Health Psychology Doctoral
Students• Clinical Pharmacist (Pharm-D)
Who We Are: Beaumont Family Medicine
Integrated Care Team
• Flinn Foundation Grant 2015
• Goal: collaboration with physician in addressing medication and behavioral health issues for whole-person care
• Primary “customer” is the physician
• Secondary “customer” is the physician’s patient
• Health Psychologist– Addresses:
mental health and substance abuse issues health behavior and lifestyle change crisis intervention
– Employs MI and CBT– Uses handouts, CDs, website resources
Integrated Care Team
• Clinical Pharmacist– Medication reconciliation
Identify discrepancies Provide patient-friendly medication lists
– Medication adherence Identify barriers Assistance programs
– Medication management Optimize dosing, monitor interactions,
adjust for renal dysfunction, etc.– Patient education– Resident/attending education
Integrated Care Team
Clinical Pharmacist
• Increasing role with psychotropic meds
– Shortage of outpatient psychiatrists with fewer medical students going into psychiatry
– Patient insurance not always accepted by psychiatrists
Enhancing Knowledge on Psychiatric Medications
• Review guidelines• Keep up with available literature• Participate in webinars/continuing education• Reach out to experts in the field• Follow-up with patients/residents after making recommendation
to analyze progress
Logistics of IC Services
• Physician request during patient’s medical visit
• Pharmacist & health psychologist offer IC during precepting (at time of huddle & throughout patient care half day)
• Anyone on the IC team can identify possible patients from daily schedule
Logistics of IC Services
• 5 to 25 minutes spent during the medical visit• Patients can return up to 3 times for 30 min f/u IC visit• “Real time” collaboration with physicians • Chart note in EHR routed to physician
– Reason patient seen– Clinical assessment of problem (beyond listing of symptoms)– Intervention with patient response as applicable– Recommendations and/or follow-up plan
Physician Survey: Barriers to Using IC Services
• Adapted from "PRIMARY CARE BEHAVIORAL HEALTH TOOL KIT” – pcpci.org
• Participation rate– n=31 (86%), 100% of faculty, 80% of residents
• Wide variability between physicians as to which items were frequently and never a barrier
• Presented survey results during noon lecture– Physicians shared strategies with each other– Generated process improvement ideas
Physician Survey: Barriers to Using IC Services(% who thought item was sometimes, frequently or very frequently a barrier)
• IC providers are part-time, I don’t know when they are here = 79% (31% very frequently)
• I forget by the end of the visit = 59%• Patient refused to see the IC provider = 55%• I don’t have time to talk to the patient about our IC services =
55%• Patient is already seeing a therapist who should be addressing
everything = 52%• Not sure how to arrange same-day visits with the IC providers
= 48%
Physician Satisfaction (n=31)
• How helpful are the IC services for your patients? (1 = low, 10 = high)– mean = 7.4– Range = 2 to 10
• How helpful are the IC services to you (i.e., helps you better serve patients)?– mean = 7.4– Range = 2 to 10
• Feedback on how to improve IC services:– Improve logistics– Provide more feedback to physicians
Process Improvements as a Result of Survey Discussion
• Increased coverage to all 10 half-day sessions• Posted IC schedule and daily changes• Increased presence during precepting• Identifying potential IC patients at beginning of session• Put up flyers about IC in exam room and lobby• Route EHR notes to physicians involved• System to identify where IC providers are• Provide more information about types of services IC can
provide
IC Primary Care Intervention GuideCONCERNS SAMPLE INTERVENTIONS
Mental Health Disorders (depression, anxiety/panic, bipolar, ADHD, anorexia, etc.)
Diagnostic assessmentCognitive Behavioral Therapy
Mindfulness Meditation
Sub-clinical emotional symptoms (sadness, worry, anger, guilt, coping with stress, etc.)
Relaxation techniquesBehavioral activation
Mindfulness Meditation
Child behavior, Family, and/or Marital problems
Parenting skillsBehavior Change Strategies
Abuse/neglect/violence/bullying Safety Plan
Difficulties in school/occupational/activities of daily living functioning
Memory assessment
Sleep difficulties, including chronic insomnia
Relaxation techniquesSleep Hygiene Strategies
Clinical Measures
• Software utilized to:
– Determine potential cost-savings associated with pharmacist interventions
– Track psychology interventions
Clinical Pharmacist: Types of InterventionsInterventions
Major Category Sub-Category
Allergy Prevented Minor Prevention
Appropriate Therapy Additional Drug Required Appropriate Labs Recommended
No Drug Ordered No Indication
Pt On Drug Recently
Chart Review ADR Chart Review Medication Review
Contraindication ADR Prevention (Minor) Pregnancy
ADR Prevention (Major)
Dosing Issues Anticoagulant Dose (Initial) Anticoagulant Dose Adjustment (f/u)
Dose Adjustment (Other) No Route
Therapeutic Recommendation Wrong Interval/Rate
Drug Interaction DI (Major) DI (Minor)
Duplicate Therapy Pt on Drug in Same Class
Other DI Consult Other
Pt education
Total Clinical Pharmacist Interventions
Clinical Pharmacist
February 18th – September 12th (4 half days/week)
425 Interventions
% of Total Interventions/CategoryAllergy Prevented
0.5%
Appro-priate
Therapy16%
Chart Review16%
Con-traindica-
tion3%
Dosing Issues26%
Drug In-teraction
2%
Duplicate Therapy
0.5%
Other36%
Clinical Pharmacist
% of Total Interventions/CategoryAllergy Prevented
0.5%
Appro-priate
Therapy16%
Chart Review16%
Con-traindica-
tion3%
Dosing Issues26%
Drug In-teraction
2%
Duplicate Therapy
0.5%
Other36%
Clinical Pharmacist
Intervention ProgressionFeb(start 2/18)
March April May June July August Sept(end 9/12)
Total 10 64 62 62 36 76 71 44
Psych Med Mgmt (%)
4(40%)
28(44%)
26(42%)
22(35%)
13(36%)
26(34%)
25(35%)
16 (36%)
PainMgmt (%)
2(20%)
7(11%)
5(8%)
5(8%)
0(0%)
6(8%)
5(7%)
1 (2%)
CombinedTotal (%)
6(60%)
35(55%)
31(50%)
27(44%)
13(36%)
32 (42%)
30(42%)
17(39%)
Clinical Pharmacist
Intervention ProgressionFeb(start 2/18)
March April May June July August Sept(end 9/12)
Total 10 64 62 62 36 76 71 44
Psych Med Mgmt (%)
4(40%)
28(44%)
26(42%)
22(35%)
13(36%)
26(34%)
25(35%)
16 (36%)
Pain Mgmt (%)
2(20%)
7(11%)
5(8%)
5(8%)
0(0%)
6(8%)
5(7%)
1 (2%)
Combined Total (%)
6(60%)
35(55%)
31(50%)
27(44%)
13(36%)
32 (42%)
30(42%)
17(39%)
Clinical Pharmacist
Intervention ProgressionFeb(start 2/18)
March April May June July August Sept(end 9/12)
Total 10 64 62 62 36 76 71 44
Psych Med Mgmt (%)
4(40%)
28(44%)
26(42%)
22(35%)
13(36%)
26(34%)
25(35%)
16 (36%)
Pain Mgmt (%)
2(20%)
7(11%)
5(8%)
5(8%)
0(0%)
6(8%)
5(7%)
1 (2%)
Combined Total (%)
6(60%)
35(55%)
31(50%)
27(44%)
13(36%)
32 (42%)
30(42%)
17(39%)
Clinical Pharmacist
Mental Health & Pain InterventionsType of Intervention # of Interventions % of Total
InterventionsPsych Med Management 160/425 38%
Type of Intervention # of Interventions % of Total Interventions
Pain Management 31/425 7%
Combined Mental Health & Pain Interventions
191/425 45%
Clinical Pharmacist
Mental Health & Pain InterventionsType of Intervention # of Interventions % of Total
InterventionsPsych Med Management 160/425 38%
Type of Intervention # of Interventions % of Total Interventions
Pain Management 31/425 7%
Combined Mental Health & Pain Interventions
191/425 45%
Clinical Pharmacist
Projected Cost Savings by CategoryInterventions
Major Category Sub-Category # of Interventions Savings/Intvn Total Cost Savings
Allergy Prevented Minor Prevention 1 $18 $18
Appropriate Therapy Additional Drug Required
48 $5332 $255,936
Appropriate Labs Recommended
10 $1112 $11,120
No Drug Ordered 2 $5332 $10,664
No Indication 5 $892 $4,460
Pt On Drug Recently 3 $136 $408
Chart Review ADR Chart Review 5 $67 $335
Medication Review 65 $67 $4,335
Contraindication ADR Prevention (Minor)
2 $18 $834
ADR Prevention (Major)
9 $417 $162
Pregnancy 1 $117 $117
Clinical Pharmacist
Projected Cost Savings by CategoryInterventions
Major Category Sub-Category # of Interventions Savings/Intvn Total Cost Savings
Allergy Prevented Minor Prevention 1 $18 $18
Appropriate Therapy Additional Drug Required
48 $5332 $255,936
Appropriate Labs Recommended
10 $1112 $11,120
No Drug Ordered 2 $5332 $10,664
No Indication 5 $892 $4,460
Pt On Drug Recently 3 $136 $408
Chart Review ADR Chart Review 5 $67 $335
Medication Review 65 $67 $4,335
Contraindication ADR Prevention (Minor)
2 $18 $834
ADR Prevention (Major)
9 $417 $162
Pregnancy 1 $117 $117
Clinical Pharmacist
Projected Cost Savings by CategoryInterventions
Major Category Sub-Category # of Interventions Savings/Intvn Total Cost Savings
Dosing Issues Anticoagulant Dose (Initial)
2 $700 $1,400
Anticoagulant Dose Adjustment (f/u)
6 $700 $4,200
Dose Adjustment (Other)
35 $1717 $60,095
No Route 3 $12 $36
Therapeutic Recommendation
63 $67 $4,221
Wrong Interval/Rate 2 $700 $1,400
Drug Interaction DI (Major) 4 $356 $1,424
DI (Minor) 3 $99 $297
Duplicate Therapy Pt on Drug in Same Class
3 $700 $2,100
Other DI Consult 60 $51 $3,060
Other 20 $0 $0
Pt education 75 $0 $0
Clinical Pharmacist
Projected Cost Savings by CategoryInterventions
Major Category Sub-Category # of Interventions Savings/Intvn Total Cost Savings
Allergy Prevented Minor Prevention 1 $18 $18
Appropriate Therapy Additional Drug Required
48 $5332 $255,936
Appropriate Labs Recommended
10 $1112 $11,120
No Drug Ordered 2 $5332 $10,664
No Indication 5 $892 $4,460
Pt On Drug Recently 3 $136 $408
Chart Review ADR Chart Review 5 $67 $335
Medication Review 65 $67 $4,335
Contraindication ADR Prevention (Minor)
2 $18 $834
ADR Prevention (Major)
9 $417 $162
Pregnancy 1 $117 $117
Clinical Pharmacist
Projected Cost Savings by CategoryInterventions
Major Category Sub-Category # of Interventions Savings/Intvn Total Cost Savings
Dosing Issues Anticoagulant Dose (Initial)
2 $700 $1,400
Anticoagulant Dose Adjustment (f/u)
6 $700 $4,200
Dose Adjustment (Other)
35 $1717 $60,095
No Route 3 $12 $36
Therapeutic Recommendation
63 $67 $4,221
Wrong Interval/Rate 2 $700 $1,400
Drug Interaction DI (Major) 4 $356 $1,424
DI (Minor) 3 $99 $297
Duplicate Therapy Pt on Drug in Same Class
3 $700 $2,100
Other DI Consult 60 $51 $3,060
Other 20 $0 $0
Pt education 75 $0 $0
Clinical Pharmacist
Projected Cost Savings: Overall
February 18th – September 12th (4 half days/week)
$366,622.00
Clinical Pharmacist
Patient Surveys, n=319(administered anonymously after each contact)
• During my visit today we talked about things that are important to me = 4.71 (1=strongly disagree, 5=strongly agree)
• Today I learned at least one skill to help me manage my problems or concerns = 4.37
• I plan to do at least one thing differently based on what I learned today = 4.34
• 96.9% listed at least one thing they planned on doing differently or one skill they planned on using– Average confidence rating = 2.62 (1=not confident, 3=very
confident)
• Phase 1: Approval (Do your homework)– Clarify purpose and desired measurable
outcomes– Identify Stakeholders (WIFM)– Be armed with data
• Phase 2: Roll Out & Implementation– Communication (x10)– Education, coaching & support
• Phase 3: On-going Evaluation & Adjustments– Plan-Do-Check-Act Cycle– Aligned incentives
Strategies for System ChangeTo Implement & Sustain Integrated Team Based Care
Culture vs. Strategy
Culture Strategy Why Culture Wins and Eats Strategy
Emotional LogicalEmotions have the
potential to overpower rational thinking
Based on the Past Based on the FutureMost people make
decision based on past experience
People Driven Business Driven Most people tend to do what is best for them
Sustainability
Peak Performing Organizations Got There By Applying Five Principles:
1. Match strategy and culture…as culture trumps strategy every time
2. Focus on a few critical shifts in behavior…change is hard, so you need to choose your battles
3. Honor the strengths of your existing culture…so major change feels more like a shared evolution vs. a top-down imposition
*Harvard Business Review, “Culture Change that Sticks” by Booz & Co. execs Jon Katzenback, Ilona Steffen, and Caroline Kronley.
Sustainability
Peak Performing Organizations Got There By Applying Five Principles:
4. Integrate formal and informal interventions…reaching people at an emotional level and tapping rational self- interest
5. Measure and monitor cultural evolution…to identify backsliding, correct course where needed, and
demonstrate tangible evidence of improvement
*Harvard Business Review, “Culture Change that Sticks” by Booz & Co. execs Jon Katzenback, Ilona Steffen, and Caroline Kronley.
Session Evaluation
Please complete and return theevaluation form to the classroom monitor
before leaving this session.
Thank you!
Patient Case• IC team engaged by physician for pain and nausea medication management and
behavioral health support for 53YOM– Suicide attempt 3 days prior
No current suicidal ideation– Stroke survivor
Difficulty with information recall– Hx of GI issues
Intolerance to all PO narcotics, except morphine Previously able to tolerate current morphine dose until recently
– Unclear if nausea related to food intake vs morphine administration
• Physician Plan:– Start pantoprazole daily before breakfast– Start ondansetron Q8H PRN for nausea– Continue morphine 15mg daily PRN– GI referral– RTC in 2 months or sooner if sxs worsen– Meet with Integrated Care Team
Patient Case• Health Psychology Intervention
– Obtained hx on previous suicide attempts Mainly d/t being overwhelmed by colitis and chronic pain Interested in counseling services
– Inquired if pt interested in being set up with a case manager for assistance with scheduling medical appts, transportation issues, and medication reminders
Pt agreeable
• Health Psychology Plan– Contact case management through pt’s insurance (Molina)– Review counseling options– Provide contact information for possible referrals for cognitive and
memory assessment
Patient Case• Clinical Pharmacist Intervention
– Pt unable to answer questions regarding his medication regimen d/t poor recall
• Clinical Pharmacist Plan– Before making changes, need to be sure an accurate hx obtained
Developed personalized pain/nausea chart for pt to fill out dailyo Reviewed with patient – Pt demonstrated understanding
through teach-back method – All questions answered– Instructed pt to take morphine before activities that typically cause
pain– Follow-up in 2 weeks to review chart documentation. Pt understands
to bring chart to clinic.
Patient CasePain/Nausea Chart
Patient CaseFollow-up Appointment #1
Pharmacist• Pt RTC in 2 weeks with chart filled out
– Taking ondansetron Q8H scheduled – Taking pantoprazole before breakfast daily w/ no issues– Pt able to take morphine 1-2 times daily PRN which controlled pain
Taking prior to activities which cause pain No nausea associated with morphine administration
o Upon review of chart, determined nausea related to food intake
• Reviewed case updates with physician– Advised pt to continue current regimen
• Exception: Take ondansetron before food intake only, not on scheduled basis
– Follow-up with PharmD in 2 weeks; continue to fill out pain/nausea chart
Health Psychology• Scheduled series of counseling sessions• Ensured case management set up through pt’s insurance
Patient CaseInsurance Audit
• Physician received audit from pt’s insurance company– Required to review/explain duplicate therapy listed– Physician requested PharmD assistance
• PharmD reviewed listed medications– Alprazolam– Lorazepam– Diazepam– Hydrocodone/acetaminophen– Morphine
• Only diazepam and morphine being rx’d by FMC physician– Muscle spasm/anxiety & chronic pain
• Pt w/ allergy listed to hydrocodone/acetaminophen in chart– Had previously requested not to be rx’d this medication d/t GI intolerance
Patient CasePharmD Review
• Lorazepam – Received 7 day supply x2 – Rx’d by psychiatrist; pt explanation valid
• Alprazolam and hydrocodone/acetaminophen rx’d by neurologist Qmonth since February 2015– Per claim sheet, rx had been dispensed consistently– Pt adamantly denied being rx’d these medications
• PharmD called all pharmacies listed in pt chart to see if rx had been picked up consistently– No prescriptions had been filled/picked up
• Pt reports his wife picks up all of his prescriptions
Patient CaseControlled substance screen
• To further investigate hydrocodone/acetaminophen and alprazolam scripts, physician ran controlled substance screen on pt– Scripts were filled at Walgreen’s (not listed as preferred
pharmacy)
• FMC physician called neurologist office and advised to stop prescribing hydrocodone/acetaminophen and alprazolam– Under assumption wife may be taking his meds
• Pt reports to PharmD that his wife admitted to picking up/taking these medications– Pt apologetic; was unaware this was going on
• States anxiety is increased since incident with wife– PharmD conducted chart review
Had previously tried the following medications for anxiety control with no improvement/intolerance:o Buspirone, paroxetine, mirtazapine, buproprion, citalopram,
venlafaxine, clonazepam• Recommend to start escitalopram 5mg daily
– Physician in agreement – will start today• Health Psychology
– Reviewed relaxation techniques– Scheduled for follow-up counseling sessions
• Follow-up home visit with FMC resident & PharmD in 1 month
Patient CaseFollow-up Appointment #2
Patient CaseHome Visit
• Unique odor/un-kept• Wife leaves and stays outside for entirety of visit• Caregiver to disabled grandson• Complete medication review
– Morphine and diazepam kept in lock-box
• Pt requests personalized medication sheet – Pt to pick up in clinic next day
• Discarded cyclobenzaprine – pt no longer taking • Pt tolerating escitalopram 5mg daily, increase dose to 10mg daily• RTC in 1 month